William E. Duke - 14 Jan 2022 Form 4 Insider Report for Kaleido Biosciences, Inc.

Role
Chief Financial Officer
Signature
/s/ William Duke, Jr.
Issuer symbol
N/A
Transactions as of
14 Jan 2022
Net transactions value
$0
Form type
4
Filing time
18 Jan 2022, 16:11:18 UTC
Previous filing
02 Sep 2021
Next filing
08 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KLDO Restricted Stock Units Award $0 +44,990 $0.000000 44,990 14 Jan 2022 Common Stock 44,990 Direct F1, F2
transaction KLDO Restricted Stock Units Award $0 +125,000 $0.000000 125,000 14 Jan 2022 Common Stock 125,000 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
F2 The restricted stock units shall vest 100% on April 30, 2022 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.
F3 The restricted stock units shall vest on the earlier of 50% on January 14, 2023 and 50% on January 14, 2024 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.